AllSight
Companies · TWST · Biological Products, (No Diagnostic Substances)

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Twist Bioscience Corp (TWST) stock — financials & valuation

Key numbers for Twist Bioscience Corp (TWST): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 39/100 — a percentile rank of Twist Bioscience Corp’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$12.5B
P / S28.9×
EV / EBITDA-110.0×
Gross margin52.0%
Operating margin-33.6%
Net margin-31.7%
Return on equity-30.7%
ROIC-42.5%
Revenue growth19.2%
Debt / equity0.0×
Dividend yield0.0%

Is Twist Bioscience Corp overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Twist Bioscience Corp’s own financial statements and shown as context, never as advice.

Aug 19, 2026No new info
Twist Bioscience registers Invenra-linked shares for resale, confirming an old deal
Aug 18, 2026Anthropic evaluator selection
Twist Bioscience lands Anthropic protein-design role, but no economics disclosed
Aug 5, 2026
Upsized equity raise brings in $345 million gross, but adds dilution
Related companies in Biological Products, (No Diagnostic Substances)
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact